ABCL vs AAPL: Which Stock is Better?
Side-by-side comparison of Abcellera Biologics Inc and Apple Inc in 2026
ABCL
Abcellera Biologics Inc
$4.16
AAPL
Apple Inc
$246.86
Key Metrics Comparison
| Metric | ABCL | AAPL | Winner |
|---|---|---|---|
| Market Cap | $1.23B | $3.66T | AAPL |
| P/E Ratio | N/A | 33.85 | AAPL |
| EPS (TTM) | $N/A | $7.55 | AAPL |
| Revenue Growth | 0.4% | 6.4% | AAPL |
| Gross Margin | -417.5% | 46.9% | AAPL |
Analyze ABCL
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABCL or AAPL a better investment?
Comparing ABCL and AAPL: Abcellera Biologics Inc has a market cap of $1.23B while Apple Inc has $3.66T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABCL and AAPL?
ABCL (Abcellera Biologics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABCL or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABCL or AAPL?
AAPL has higher revenue growth at 6.4% vs 0.4% for ABCL.
Which company is more profitable: ABCL or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to -417.5% for ABCL.
Which is the larger company: ABCL or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.66T compared to $1.23B for ABCL.
Should I buy ABCL or AAPL in 2026?
Both ABCL and AAPL have investment merit. ABCL trades at $4.16 while AAPL trades at $246.86. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABCL and AAPL stock?
Key differences: Market Cap ($1.23B vs $3.66T), P/E Ratio (N/A vs 33.8x), Revenue Growth (0.4% vs 6.4%), Gross Margin (-417.5% vs 46.9%).